Elan Reports Fourth Quarter and Full-Year 2006 Financial Results
Genetic Engineering News (press release) - New Rochelle,NY,USA
As we have demonstrated with Tysabri, we will continue to work closely with the patients and their physicians to seek solutions that will meaningfully ...

Elan 4Q Loss Narrows on Tysabri Sales
Forbes - NY,USA
PLC reported a smaller fourth-quarter loss and higher sales Tuesday, citing the expansion of its multiple sclerosis-fighting drug Tysabri. ...
See all stories on this topic

Elan sees quarterly losses narrow
IrishExaminer.com - Ireland
Elan said sales of the multiple sclerosis treatment Tysabri, which was withdrawn from sale two years ago because of the death of two patients who had taken ...

Ryanair names date for share split
RTE.ie - Ireland
Elan chief executive Kelly Martin tells Emma McNamara the re-introduction of Tysabri in the US went better than expected. Rapidly falling prices of notebook ...